Matias Serebrinsky
Investing Profile
Sweet spot: $500K
Range: $100K–$2.5M
Sector and stage focus
- Seed: Pharmaceuticals, BioTech, DeepTech, Health IT, Digital Health
- Series A: BioTech, Pharmaceuticals, Health IT, DeepTech, Digital Health
- general: Investors who were founders, Investors who invested in female founders, Investors who invested in diverse founders, San Francisco Bay Area
- Pre-seed: Pharmaceuticals, DeepTech, Health IT, Digital Health, BioTech
Recent investments by Matias Serebrinsky
Matias Serebrinsky has 7 named past investments in the public record. The most recent:
| Company | Stage | Date | Round size |
|---|---|---|---|
| Delix Therapeutics | Series A | Sep 2021 | $70M |
| Mindstate | Seed+ | Sep 2021 | $250K |
| TRIPP | Series A | Sep 2017 | $4M |
| Maya Health | Seed | Oct 2020 | $100K |
| Beckley Psytech | Series B | Jun 2021 | $1 |
| ATAI Life Sciences | Series D | Feb 2021 | $3.6M |
| Journey Clinical | Seed | Aug 2021 | $250K |
Frequent co-investors
Matias Serebrinsky has co-invested with: Ken Belotsky, Eric Brook, Matt Mullenweg.
Is Matias Serebrinsky a fit for your round?
Upload your pitch deck and see whether Matias Serebrinsky appears in your top 20 matches.
Find investors for your deck